SCHEMBL4728704

SCHEMBL4728704

S=C(Nc1cccc(Br)c1)NC1CCN(c2ncnc3cc(Cl)ccc23)CC1.S=C(Nc1ccccc1Br)NC1CCN(c2ncnc3cc(Cl)ccc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
PAK1 Q13153 1/20 0.44
PDGFRB P09619 2/20 0.44
PIM1 P11309 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
GRIK1 P39086 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582847 0.93 CYP1A2 (0.52) EGFRCYP1A2CYP2D6PAK1PDGFRB
SCHEMBL4583190 0.93 CYP1A2 (0.53) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4728075 0.88 KDM4E (0.44) ALDH1A1MAPTMAPK1
SCHEMBL4582925 0.86 PAK1 (0.57) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4726802 0.86 PAK1 (0.54) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4584207 0.85 CYP1A2 (0.56) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4583402 0.84 CYP1A2 (0.54) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4583169 0.82 CYP1A2 (0.53) CYP1A2CYP2D6PAK1PDGFRBALDH1A1
SCHEMBL4582328 0.82 CYP1A2 (0.53) CYP1A2CYP2D6PAK1PDGFRBMEN1
SCHEMBL4583131 0.81 PDGFRB (0.53) CYP1A2CYP2D6PAK1PDGFRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed